Top 10+ Pharmaceutical Companies In Chicago In 2021
← Visit blog

Top 10+ Pharmaceutical Companies In Chicago In 2021

Updated on March 11th, 2021

Top 10+ Pharmaceutical Companies In Chicago In 2021

A hand curated list of 10+ top pharmaceutical companies in Chicago.
Whether you run a digital agency, a B2B company, or just want to connect with fast growing companies, this is the list for you.
In our premium lists, we also include: • 20+ data points for each company
• Services they’re likely to outsource
• CEO Information & Email
If you’re interested in our premium lists, consider subscribing to our monthly report of tech companies.


Table Of Contents

  1. Kalderos ($1M to $10M)
  2. ClostraBio ($1M to $10M)
  3. ALTATHERA Pharmaceuticals ($1M to $10M)
  4. SonarMD ($1M to $10M)
  5. Cresco Labs ($10M to $50M)
  6. Medexus Pharma ($1M to $10M)
  7. MATTER (Less than $1M)
  8. Xeris Pharmaceuticals (Less than $1M)
  9. Seurat Therapeutics (Less than $1M)
  10. HCHB Cressey ($10M to $50M)
  11. ResQ Pharma (Less than $1M)
  12. Cosmos Holdings ($10M to $50M)
  13. Lumere ($10M to $50M)
  14. Waveseer ($10M to $50M)
  15. Featureform ($10M to $50M)
  16. Aquarius Biotechnologies ($10M to $50M)


  1. Kalderos ($1M to $10M)

    Kalderos is the creator of a drug discount management solution. It provides a SaaS-based drug discount management solution, which identifies, checks, and resolves non-compliance. Using models and machine learning processes, Kalderos detects inconsistencies overlooked by current methods, providing material benefits by eliminating waste. It was founded in 2016 and is headquartered in Chicago, Illinois.

    • $1M to $10M annual revenues
    • 51-100 employees
    • $28M raised in June, 2020
    • 3 founders
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →


  2. rolling armchair beside table


  3. ClostraBio ($1M to $10M)

    ClostraBio develops drugs that can prevent allergic reactions to food. It is dedicated to understanding and treating food allergies and other diseases of the immune system. The company is discovering and developing new therapeutics that modulate the protective ability of the microbe. ClostraBio’s scientific team has made key discoveries that highlight the importance of the intestinal microbiota in regulating allergic sensitization to food. The company is committed to a deeper understanding of the role of intestinal microbes in gut barrier function and determining the mechanisms of barrier protection.

    • $1M to $10M annual revenues
    • 1-10 employees
    • $3.5M raised in January, 2018
    • 2 founders
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →


  4. brown and white table and chairs


  5. ALTATHERA Pharmaceuticals ($1M to $10M)

    ALTATHERA Pharmaceuticals provides critical care and alternative therapeutics for unmet medical needs of patients. It is a commercial-stage biopharmaceutical company that identifies, acquires, develops, and commercializes therapies to address patients with severe and rare disorders for which few effective treatments are available. It was founded in 2009 and is headquartered in Chicago, Illinois.

    • $1M to $10M annual revenues
    • 11-50 employees
    • $3.4M raised in December, 2016
    • 1 founder
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →




  6. SonarMD ($1M to $10M)

    SonarMD is a health care company based in Chicago, Illinois.

    • $1M to $10M annual revenues
    • 1-10 employees
    • $10M raised in December, 2018
    • 1 founder
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →


  7. people using desktop computer inside office


  8. Cresco Labs ($10M to $50M)

    Cresco Labs is a vertically-integrated multi-state cannabis operator inciting the progressive evolution of the medical cannabis industry. It grows, manufactures, and distributes cannabis using a consumer-packaged-goods (CPG) approach. The company is on a mission to normalize, professionalize, and revolutionize cannabis. It was founded in 2013 and is headquartered in Chicago, Illinois.

    • $10M to $50M annual revenues
    • 501-1000 employees
    • $125M raised in January, 2021
    • 5 founders
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →


  9. man in gray sweatshirt sitting on chair in front of iMac


  10. Medexus Pharma ($1M to $10M)

    Medexus Pharma is a biotechnology company based in Chicago, Illinois.

    • $1M to $10M annual revenues
    • 51-100 employees
    • $20M raised in May, 2020
    • 1 founder
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →


  11. men using computers


  12. MATTER (Less than $1M)

    MATTER is a community of healthcare entrepreneurs and industry leaders working together in a shared space to individually and collectively fuel the future of healthcare innovation. It connects and promotes the collaboration between scientists, physicians, health technology entrepreneurs and other industry partners, in order to bring next-generation products and services to market. MATTER was founded in April 2014 and is based in Chicago, Illinois.

    • Less than $1M annual revenues
    • 11-50 employees
    • $4.4M raised in November, 2014
    • 1 founder
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →


  13. people sitting beside rectangular brown table with laptops


  14. Xeris Pharmaceuticals (Less than $1M)

    Xeris is a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use, liquid-stable injectables. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous (SC) and intramuscular (IM) delivery of highly concentrated, non-aqueous, ready-to-use formulations of peptides, proteins, antibodies, and small molecules using syringes, auto-injectors, multi-dose pens, and infusion pumps. Xeris’ platforms have the potential to offer distinct advantages over existing formulations of marketed and development-stage products. In particular, XeriSol and XeriJect offer the opportunity to eliminate reconstitution, enable long-term room temperature stability, significantly reduce injection volume, and eliminate the requirement for intravenous (IV) infusion. These attributes can lead to products that are easier to use by patients, caregivers, and health practitioners and reduce costs for payers and the healthcare system.

    • Less than $1M annual revenues
    • 101-250 employees
    • $85M raised in September, 2019
    • 1 founder
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →


  15. people having meeting on rectangular brown table


  16. Seurat Therapeutics (Less than $1M)

    Seurat Therapeutics sprung from the University of Chicago and is currently based at the Polsky Exchange. They are a team passionate about innovating migraine care and accelerating the translation of scientific discoveries into life-changing medicine. The science behind Seurat Therapeutics is based on years of research from the University of Chicago medical center.

    • Less than $1M annual revenues
    • 1-10 employees
    • $0.5M raised in October, 2018
    • 3 founders
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →


  17. man in black jacket sitting on chair


  18. HCHB Cressey ($10M to $50M)

    HCHB Cressey Holdings, Inc. was incorporated in 2011 and is based in Chicago, Illinois.

    • $10M to $50M annual revenues
    • 11-50 employees
    • $28.6M raised in March, 2011
    • 2 founders
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →


  19. three women sitting around table using laptops


  20. ResQ Pharma (Less than $1M)

    ResQ Pharma is a research & development company. Its lead program, LipidRescue Therapy (LRT) is an already used off-label treatment for various non-opiate drug overdoses and poisonings including all local anesthetics (Lidocaine, Bupivacaine, etc...), benzodiazepines and psychotherapeutics (all antidepres). The Company was formed to commercialize LRT which is a repurposing of a lipid emulsion that is FDA and EMA approved as a nutritional supplement. ResQ Pharma plans to file applications for market approval for both the EU and USA by the 1st quarter of 2017. Applications for Orphan Drug Designation are pending with both the FDA and EMA currently. This lipid emulsion has been used around the world since 2010 as Lipid Rescue Therapy (LRT). The problem is that it is not regulatorily approved as a treatment for overdoses and poisonings. Therefore it cannot be marketed and many in the healthcare community are not aware of product. Approximately 47,000 people died in 2015 from drug overdoses and poisonings, approximately 40% likely treatable with LRT.

    • Less than $1M annual revenues
    • 11-50 employees
    • $1M raised in September, 2020
    • 2 founders
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →


  21. rectangular brown wooden table


  22. Cosmos Holdings ($10M to $50M)

    Cosmos Holdings focuses on identifying, acquiring, developing, and commercializing different medicines to improve patients’ lives. It has a large network of over 160 clients & vendors in Germany, United Kingdom, United Arab Emirates, Denmark, Italy, France, Singapore, Ireland, Sweden, Poland, Netherlands, and Greece. We have offices and distribution centers in Thessaloniki, Greece & In Harlow, UK. The company is a fully reporting International Holding company, incorporated in 2009, listed in the OTCQB marketplace ticker COSM.

    • $10M to $50M annual revenues
    • 11-50 employees
    • $1.5M raised in May, 2019
    • 2 founders
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →


  23. group of people sitting beside rectangular wooden table with laptops


  24. Lumere ($10M to $50M)

    Lumere (previously Procured Health) is an organization comprised of clinicians, researchers, pharmacists, and strategic thought leaders focused on helping health systems eliminate unwarranted clinical variation and cut unnecessary costs—specifically related to device and drug selection and utilization. It was incorporated in 2012 and is based in Chicago, Illinois.

    • $10M to $50M annual revenues
    • 51-100 employees
    • $5M raised in February, 2019
    • 3 founders
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →




  25. Waveseer ($10M to $50M)

    Waveseer is a premier cultivator and manufacturer of superior quality cannabis products. It is an expert at growing high-grade cannabis and producing effective, safe-to-use infused products, that will enhance the qualified consumers' day-to-day life. Waveseer has spent years and committed significant dollars to research and development with respect to cultivation and manufacturing processes. The company was founded in 2013 and is headquartered in Chicago, Illinois.

    • $10M to $50M annual revenues
    • 11-50 employees
    • $0.2M raised in May, 2015
    • 1 founder
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →


  26. people sitting and using laptops


  27. Featureform ($10M to $50M)

    Featureform builds machine learning tools for pharmaceutical and biotechnology companies.

    • $10M to $50M annual revenues
    • 1-10 employees
    • $2.3M raised in January, 2021
    • 2 founders
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →


  28. grey wooden table and black leather rolling chairs


  29. Aquarius Biotechnologies ($10M to $50M)

    Aquarius Biotechnologies, Inc., a biotechnology company, develops proprietary drug delivery platform to improve existing drugs. It specializes in the fields of biotechnology, medicine, and pharmaceutical. The company was founded in 2013 and is based in Chicago, Illinois.

    • $10M to $50M annual revenues
    • 1-10 employees
    • $0.3M raised in October, 2013
    • 1 founder
    • CEO Info & Email: Available in our premium reports 🔐
    • Likely to outsource: Available in our premium reports 🔐

    Visit Website →


  30. brown wooden table and chairs